Marc A. Cohen

Chief Executive Officer, OPNET TECHNOLOGIES INC.

Companies

C4 Therapeutics (United States)Board member Oct 1, 2020 to Jun 23, 2022¹
Korro Bio, Inc.Board member Oct 2, 2019 to Jun 23, 2022²
C4 Therapeutics (United States)Chief executive officer Oct 1, 2020 to Oct 1, 2020¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

C4 Therapeutics (United States) CCCC1,975,381 shares³$5.7M at $2.88Jan 18, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 4, 2022Granted 657 shares at $31.58 of C4 Therapeutics (United States)³
Oct 4, 2021Granted 461 shares at $44.99 of C4 Therapeutics (United States)⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARC4 Therapeutics (United States), Board member
2
SEC EDGARKorro Bio, Inc., Board member
3
SEC EDGARC4 Therapeutics (United States) shares after the filing of Jan 18, 2022
4
SEC EDGARForm 4 filed Oct 5, 2021